NO20092695L - Profylaktisk eller terapeutisk middel for alopeki - Google Patents

Profylaktisk eller terapeutisk middel for alopeki

Info

Publication number
NO20092695L
NO20092695L NO20092695A NO20092695A NO20092695L NO 20092695 L NO20092695 L NO 20092695L NO 20092695 A NO20092695 A NO 20092695A NO 20092695 A NO20092695 A NO 20092695A NO 20092695 L NO20092695 L NO 20092695L
Authority
NO
Norway
Prior art keywords
alopecia
therapeutic agent
prophylactic
disclosed
tetramethylcyclohexanol
Prior art date
Application number
NO20092695A
Other languages
English (en)
Norwegian (no)
Inventor
Akiko Nakao
Natsuko Uematsu
Akiko Takahashi
Shin-Ichi Yokota
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of NO20092695L publication Critical patent/NO20092695L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
NO20092695A 2006-12-20 2009-07-17 Profylaktisk eller terapeutisk middel for alopeki NO20092695L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006343254 2006-12-20
PCT/JP2007/074496 WO2008075735A1 (ja) 2006-12-20 2007-12-20 脱毛症の予防又は治療剤

Publications (1)

Publication Number Publication Date
NO20092695L true NO20092695L (no) 2009-09-15

Family

ID=39536362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092695A NO20092695L (no) 2006-12-20 2009-07-17 Profylaktisk eller terapeutisk middel for alopeki

Country Status (16)

Country Link
US (1) US20100022604A1 (ru)
EP (1) EP2100588A4 (ru)
JP (1) JPWO2008075735A1 (ru)
KR (1) KR20090100416A (ru)
CN (1) CN101610751B (ru)
AU (1) AU2007335379B2 (ru)
BR (1) BRPI0717919A2 (ru)
CA (1) CA2673841A1 (ru)
HK (1) HK1138204A1 (ru)
IL (1) IL199177A0 (ru)
NO (1) NO20092695L (ru)
NZ (1) NZ578391A (ru)
RU (1) RU2457826C2 (ru)
TW (1) TW200833323A (ru)
WO (1) WO2008075735A1 (ru)
ZA (1) ZA200904328B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI534142B (zh) 2011-03-15 2016-05-21 大正製藥股份有限公司 Azole derivatives
JP6020396B2 (ja) * 2012-09-12 2016-11-02 大正製薬株式会社 アゾール誘導体を含有する医薬
DE102016125344A1 (de) * 2016-12-22 2018-06-28 Peter Jürgensen Zubereitung zur Verwendung bei der Behandlung des erblich bedingten Haarausfalls
US20200352736A1 (en) * 2019-05-09 2020-11-12 DDS Company, Inc. Tissue Borne Stackable Foundation Guide and Method of Making and Using Same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0159766B1 (ko) 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
DK0584223T3 (da) 1991-05-09 2000-03-13 Vertex Pharma Hidtil ukendte immunsuppressive forbindelser
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5945441A (en) * 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
GB9804426D0 (en) 1998-03-02 1998-04-29 Pfizer Ltd Heterocycles
CA2333997A1 (en) 1998-06-02 1999-12-09 Bristol-Myers Squibb Company Neurotrophic difluoroamide agents
US6228872B1 (en) 1998-11-12 2001-05-08 Bristol-Myers Squibb Company Neurotrophic diamide and carbamate agents
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
JP4780429B2 (ja) * 2000-04-07 2011-09-28 大正製薬株式会社 ミノキシジル含有製剤
JP4221989B2 (ja) 2002-09-30 2009-02-12 大正製薬株式会社 オキサジアゾール誘導体
JP4240978B2 (ja) * 2002-09-30 2009-03-18 大正製薬株式会社 アリールオキシメチルオキサジアゾール誘導体
JP2006527201A (ja) 2003-06-06 2006-11-30 スミスクライン・ビーチャム・コーポレイション Ｉｌ−８受容体アンタゴニスト

Also Published As

Publication number Publication date
RU2009127776A (ru) 2011-01-27
CN101610751B (zh) 2012-03-21
TW200833323A (en) 2008-08-16
AU2007335379A1 (en) 2008-06-26
CA2673841A1 (en) 2008-06-26
EP2100588A1 (en) 2009-09-16
HK1138204A1 (en) 2010-08-20
AU2007335379B2 (en) 2012-06-14
ZA200904328B (en) 2010-09-29
RU2457826C2 (ru) 2012-08-10
WO2008075735A1 (ja) 2008-06-26
KR20090100416A (ko) 2009-09-23
EP2100588A4 (en) 2011-01-19
US20100022604A1 (en) 2010-01-28
IL199177A0 (en) 2010-03-28
NZ578391A (en) 2011-02-25
CN101610751A (zh) 2009-12-23
JPWO2008075735A1 (ja) 2010-04-15
BRPI0717919A2 (pt) 2013-11-05

Similar Documents

Publication Publication Date Title
IL199673A0 (en) 5-(1,3,4- oxadiazol-2-yl)-1h-indazole and 5-(1,3,4 thiadiazol-2-yl)-1h-indazole derivatives as sgk inhibitors for the treatment of diabetes
NO20090628L (no) Pyridizinon derivativater
DK2069374T4 (da) Krystallinske solvater af (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl)phenyl)-d-glucitolderivater med alkoholer som sglt2-inhibitorer til behandling af diabetes
NO20091183L (no) Derivater av 4-(N-azacykloalkyl)-anilider, fremgangsmåte for fremstilling av slike forbindelser, preparater omfattende slike forbindelser samt anvendelse av slike forbindelser for forhindring eller behandling av sykdom
MX2007005546A (es) Tiazoles de 5-heteroarilo y su uso como inhibidores p13k.
NO20084912L (no) Bisykliske derivater som CETP-inhibitorer
NO20073853L (no) Faste, oralt applikerbare farmasoytiske administreringsformer inneholdende nvaroksaban med modifisert frigivelse
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
AR062860A1 (es) Combinaciones terapeuticas 482
WO2007095618A3 (en) Benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
NO20090738L (no) Tilveiebringelse av EP2 agonister, fremgangsmate for fremstilling derav, farmasoytiske sammensetninger inneholdende disse forbindelser og fremgangsmater for anvendelse av forbindelsene og sammensetningene for a senke intraokkulaert trykk og behandle glaukom
NO20084853L (no) Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni
NO20090346L (no) Pyrazolderivater som inhibitorer av cytokrom P450
NO20092691L (no) 4-hydroksy-2-okso-2,3-dihydro-1,3-benzotiazol-7yl-forbindelser for modulering av B2-adrenoreseptoraktivitet
MX2009002239A (es) Derivados de 5-(2-furil)-1,3-tiazol util como inhibidores de fosfatidilinositol 3-cinasa.
CL2007000918A1 (es) Compuestos derivados de enfumafungina, inhibidores de (1,3)-beta-d-glucanosintetasa; composicion farmaceutica; y uso para tratar una infeccion fungica.
DK2073805T3 (da) Fremgangsmåder til dosering af en oralt aktiv 1,2,4-oxadiazol til terapi for suppression af nonsens-mutation
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
CL2007003540A1 (es) Compuestos derivados de macrociclos, inhibidores de la proteasa serina de hepatitis c; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
NO20083036L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon
NO20085271L (no) Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni
NZ598750A (en) Therapeutic agent for mood disorders
NO20091353L (no) Serine hydrolaseinhibitorer
DK2170857T3 (da) 3',4',5-trimethoxyflavonderivater som stimulerende middel ved slimafsondring, tilsvarende fremgangsmåde og farmaceutisk præparat, der indeholder disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application